News | March 10, 2015

Acute Myocardial Infarction Patient Treated with New Mechanical Thrombectomy Device

Aspire system removes thrombus occluding blood vessel in coronary arteries

Aspire, Control Medical, thrombectomy, atherectomy devices, cath lab

March 10, 2015 —George Adams, M.D., an interventional cardiologist with North Carolina Heart and Vascular, successfully treated a patient having an acute myocardial infarction (AMI) with the Aspire Mechanical Thrombectomy System.

The patient presented with chest pain, nausea and shortness of breath. An angiogram was performed and showed a long segment of thrombus occluding the ramus intermedius, a blood vessel in the coronary arteries. Adams used the Aspire Mechanical Thrombectomy device to remove the thrombus, and then he was able to angioplasty and stent the artery, relieving the patient from his symptoms.

"When a patient is having an AMI, removing the thrombus in the symptomatic artery is important," said Adams. "The Aspire device allows me to remove the thrombus quickly, helping to relieve the patients symptoms."

The Aspire System allows clinicians to instantly start, stop, increase, decrease, pulse or maintain thrombectomy force during the procedure. Aspire Mechanical Aspirators also aspirate up to 280ml, almost 10 times more than basic syringe systems, without multiple messy and time-consuming catheter connections, disconnections and re-connections.

The patented Aspire RX-LP6 Mechanical Thrombectomy System includes an Aspire Mechanical Aspirator (drive unit/pump) and a low-profile rapid-exchange (RX) thrombectomy catheter. Mechanical aspirators are also available alone and may be connected to any thrombectomy catheter the clinician chooses to use. Control Medical also manufactures Aspire Max Mechanical Thrombectomy Systems with larger over-the-wire (OTW) thrombectomy catheters for use in the peripheral vasculature.

For more information: www.controlmedtech.com

Related Content

Gallery | Cath Lab | October 31, 2019
This is a photo essay of the interventional cardiology and structural heart technologies on the expo floor and discus
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Cath Lab | October 28, 2019
Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from imaging vendors.
Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

News | Cath Lab | October 28, 2019
October 28, 2019 — Leaders within University Hospitals and the Harrington Heart and Vascular Institute had a vision t
OmniVision Announces Guinness World Record for Smallest Image Sensor

OmniVision's OVM6948 CameraCubeChip, a fully packaged, wafer-level camera module measuring 0.65mm x 0.65mm x 1.158mm, built on OmniVision's OV6948, winner of the Guinness World Record for “The Smallest Image Sensor Commercially Available.”

News | Cath Lab | October 22, 2019
October 22, 2019 — OmniVision Technologies Inc.
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. 

Feature | Cath Lab | October 03, 2019
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with pe
Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders, suffers chest pain
News | Cath Lab | October 02, 2019 | Dave Fornell, Editor
October 2, 2019 — Democratic presidential candidate Sen.
Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival
News | Cath Lab | September 25, 2019
Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting stents in randomized...
Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
Overlay Init